Comparison of bamlanivimab with or without etesevimab and casirivimab-imdevimab in clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

Yang, Mingyang; Liu, Junzhao; Luo, Linna; Dai, Kaili

Yang, Mingyang; Liu, Junzhao; Luo, Linna; Dai, Kaili.

Afiliación

Yang M; Department of Emergency and Critical Care Medicine, West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu J; Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University.
Luo L; Department of Emergency and Critical Care Medicine, West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Dai K; Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University.

J Chemother ; : 1-3, 2024 May 09.

Article en En | MEDLINE | ID: mdl-38721976

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google